Mechanisms of the synergistic interactions between organic calcium channel antagonists and various neuromuscular blocking agents.

The effects of Mn2+, neomycin and four organic Ca2(+)-channel antagonists (OCA): nicardipine, nifedipine, diltiazem and verapamil on the neuromuscular blocking activities of tubocurarine, succinylcholine (SCh), decamethonium and neomycin were studied in isolated mouse phrenic nerve-diaphragm preparations. The effective concentration of SCh for 50% inhibition (IC50) of single indirect twitch responses were reduced markedly by more than 3-fold when the preparations were pretreated with OCA at 10 microM; the latter alone did not appreciably affect the indirect twitch response or the amplitude of miniature endplate potentials. The neuromuscular blocking effect of decamethonium was also enhanced synergistically by OCA to a similar extent. On the other hand, under the comparable condition. the combined uses of OCA plus tubocurarine or neomycin, neomycin plus tubocurarine or SCh, and Mn2+ plus tubocurarine, SCh or neomycin all resulted in insignificant potentiation. These results suggest that OCA have a specific effect to enhance the agonist effect of depolarizing agents on nicotinic acetylcholine receptors. Nicardipine at 2 microM non-competitively inhibited depolarizations of endplates elicited by SCh and decamethonium and abolished them completely at 10 microM nicardipine. The IC50's in inhibiting endplate potentials and miniature endplate potentials by SCh and decamethonium were also reduced 2 to 3.5-fold by nicardipine. It is inferred that OCA are endowed with a unique capability to allosterically affect the postsynaptic nicotinic acetylcholine receptor, promoting its desensitization liability, hence synergistic interaction with depolarizing agents. Presynaptic effects of OCA are probably not involved.

[1]  S. Hong,et al.  Nicardipine inhibits axon conduction but causes dual changes of acetylcholine release in the mouse motor nerve. , 1989, Canadian journal of physiology and pharmacology.

[2]  L. Hwang,et al.  Selective antagonism to succinylcholine‐induced depolarization by α‐bungarotoxin with respect to the mode of action of depolarizing agents , 1989, British journal of pharmacology.

[3]  M. Lazdunski,et al.  Targets for calcium channel blockers in mammalian skeletal muscle and their respective functions in excitation-contraction coupling. , 1988, Biochemical and biophysical research communications.

[4]  K. Campbell,et al.  Sequence and expression of MRNAs encoding the α1 and α2 subunits of a DHP-sensitive calcium channel , 1988 .

[5]  R. Milne,et al.  Verapamil, neuromuscular transmission and the nicotinic receptor. , 1988, European journal of pharmacology.

[6]  L. Chiou,et al.  Neuromuscular block by verapamil and diltiazem and inhibition of acetylcholine release , 1988, Brain Research.

[7]  J. Baeyens,et al.  Differential effects of calcium channel blocking agents on pancuronium- and suxamethonium-induced neuromuscular blockade. , 1988, British journal of anaesthesia.

[8]  F. Foldes,et al.  Potentiation of Neuromuscular Blocking Agents by Calcium Channel Blockers in Rats , 1988, Anesthesia and analgesia.

[9]  R. Wachtel Effects of diltiazem and verapamil on responses to acetylcholine , 1987, British journal of pharmacology.

[10]  L. Adam,et al.  Augmentation of succinylcholine-induced neuromuscular blockade by calcium channel antagonists , 1986, Neuroscience Letters.

[11]  J. Baeyens,et al.  Effects of calcium channel blockers on neuromuscular blockade induced by aminoglycoside antibiotics. , 1986, European journal of pharmacology.

[12]  F. A. Wali Verapamil intensifies neuromuscular blockade produced by gallamine and pancuronium at the chick neuromuscular junction. , 1986, Pharmacological research communications.

[13]  L. Adam,et al.  Nicotinic Receptor Blockade by Calcium Channel Antagonists in Frog Skeletal Muscle , 1986 .

[14]  N. Slater,et al.  Trifluoperazine and calcium antagonists accelerate cholinergic desensitization inAplysia neurons , 1985, Brain Research.

[15]  J. Lambert,et al.  Displacement of [3H]phencyclidine binding to Torpedo electric organ membrane by calcium channel antagonists. , 1984, Biochemical pharmacology.

[16]  R. Katz,et al.  Potentiation of Neuromuscular Blockade by Verapamil , 1984, Anesthesiology.

[17]  D. A. Lathrop,et al.  Slow inward calcium currents have no obvious role in muscle excitation–contraction coupling , 1982, Nature.

[18]  L. Magazanik,et al.  Effect of the desensitization-potentiating agent SKF-525a on frog end-plate currents. , 1982, European journal of pharmacology.

[19]  R. Wadsworth,et al.  Local anaesthetic activity of organic calcium antagonists: relevance to their actions on smooth muscle. , 1982, European journal of pharmacology.

[20]  C. Chang,et al.  Effects of chronic treatment with various neuromuscular blocking agents on the number and distribution of acetylcholine receptors in the rat diaphragm. , 1975, The Journal of physiology.

[21]  P. Bentley,et al.  The effects of verapamil on metabolism and contractility of the toad skeletal muscle. , 1973, The Journal of pharmacology and experimental therapeutics.

[22]  W. Paton,et al.  The margin of safety of neuromuscular transmission , 1967, The Journal of physiology.

[23]  E. Bulbring Observations on the isolated phrenic nerve diaphragm preparation of the rat. , 1946, British journal of pharmacology and chemotherapy.